Genexine has ranked among the top searched stocks on 4 days within the past month.
As of 11:31 AM on the 23rd, Genexine is trading at 98,100 KRW, down 2.0% from the previous day. This represents a decline of 8.57% compared to February 18. Genexine is known as a company specializing in the development of biopharmaceuticals.
Today, foreigners have tentatively been recorded as net buyers of 4,000 shares. Over the past 5 days, individual investors have net purchased 406,316 shares, while foreigners and institutions have net sold 338,087 shares and 73,006 shares, respectively.
On February 18, Genexine was a market issue with the headline "Soars on news of immune-oncology technology export."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
